Prognostic value of immune-related adverse events in patients with advanced tumors treated with PD-1/PD-L1 inhibitors
ZHANG Shupei
YANG Lei
GU Kangsheng
Machine-generated Keywords:
Publication Date:2022-02-28
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:8( 109-116 )
Chinese Clinical Oncology

Chinese Clinical Oncology

ISTICPKU
ISSN:1009-0460
Year, Vol.(Issue):2022,27(2)